Month: June 2022

SHANGHAI, China, June 20, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced the appointment of Donna Ambrosino, M.D., and Ralf Clemens, M.D., Ph.D., to the company’s Board of Directors. “We are pleased to welcome Donna and Ralf, who have been members of our Vaccine Scientific Advisory Board since 2020 and have been instrumental to the development of our lead COVID-19 vaccine candidate, to our Board of Directors and look forward to their additional contributions to our overall corporate strategy and governance,” said Joshua Liang, Chief Executive Officer and Executive Director of Clover. “Donna’s background as a celebrated researcher, infectious disease expert, and proven biotech...

Press Release Nathalie Sénéchault to be appointed Chief Financial Officer of Atos Paris, June 19, 2022 – Atos today announces that Stéphane Lhopiteau will leave the Group later during the course of the second semester 2022 and will be succeeded by Nathalie Sénéchault as Chief Financial Officer of the Group. The contemplated separation of the Group announced at a Capital Markets Day on June 14th, is meant to lead to a complete reorganization of the Atos Group and in this particular case, its finance department. Thus, the appointment of two CFOs has already been announced for each of the contemplated two companies to be formed out of Atos: Anil Agrawal for Evidian (BDS+Digital) and Darren Pilcher for New Atos (Tech Foundations). In this context, Mr. Lhopiteau will leave the Group during the second half of the year, when the separation is...

Santiago, Chile, June 18, 2022 (GLOBE NEWSWIRE) — LATAM Airlines Group and its subsidiaries in Brazil, Chile, Colombia, Ecuador, Peru and the United States announced that the U.S. Bankruptcy Court for the Southern District of New York approved the group’s Plan of Reorganization filed by LATAM in the context of its Chapter 11 reorganization proceeding. Backed by nearly all of LATAM’s creditors, the Plan is the result of months of negotiations among major stakeholders, which included an extensive mediation period. The Plan complies with U.S. and Chilean legal requirements. The confirmation order issued today by the U.S. Court represents the latest milestone in the U.S. Chapter 11 process initiated by LATAM to ensure its long-term sustainability. “We are very satisfied with the judge’s confirmation of our restructuring...

Press Release Agreement with BARDA on ZENEO® Midazolam  BARDA places a firm order of $60m to CROSSJECT for initial procurement of ZENEO® Midazolam into the U.S. Strategic National Stockpile1 as soon as FDA Authorization is obtainedBARDA also financially supports the U.S. late-stage development and regulatory activities necessary to obtain FDA approval of ZENEO® Midazolam 10mg and a new pediatric dose ZENEO® Midazolam auto injectorBARDA has the option to procure additional ZENEO® Midazolam auto injectors from CROSSJECTDijon, June 18th 2022   CROSSJECT (ISIN: FR0011716265; Ticker: ALCJ), a specialty pharma company that is developing and will soon be marketing a portfolio of drug / device combinations for use in emergency situations, is announcing an agreement with BARDA on ZENEO® Midazolam. Patrick Alexandre, Crossject CEO, said:...

VANCOUVER, British Columbia, June 17, 2022 (GLOBE NEWSWIRE) — Western Resources Corp. (TSX: WRX) (the “Company”) is pleased to announce that its Regina-based subsidiary Western Potash Corp. (“Western”) completed a Collaborative Project Planning Session with its key contractors and staff to officially kick off the restart of the Milestone Project (“Project”) in order to complete the process facilities and solution mining development. Key Project representatives participated in a workshop style planning session in Regina to review and gain alignment on key aspects of the project timeline and readiness for start-up, leading into the full ramp up of operations which is expected to happen in mid 2023. The kick off planning session was attended by Western executives and staff and more than 30 people from several different key organizations,...

XIAMEN, China, June 17, 2022 (GLOBE NEWSWIRE) — Blue Hat Interactive Entertainment Technology (“BHAT” or the “Company”) (NASDAQ: BHAT), a producer, developer and operator of augmented reality interactive entertainment games, toys and educational materials in China, today announced that it intends to offer in an underwritten public offering its ordinary shares and pre-funded warrants to purchase ordinary shares. The pre-funded warrants shall be offered at the same price per share as the ordinary shares, less the $0.01 per share exercise price of each pre-funded warrant. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes, which include, but are not limited to, advancing and diversifying the company’s product portfolio, and general and administrative...

New York, NY, June 17, 2022 (GLOBE NEWSWIRE) — Global Tech Industries Group, Inc. (OTCQB: GTII) (“GTII” or the “Company”), www.gtii-us.com, a Nevada corporation, announced today that it has been in communication with FINRA regarding its digital dividend recently offered to shareholders of record as of May 9, 2022. The Company submitted its application to distribute the dividend to the FINRA portal on May 3, 2022. FINRA responded with several questions for the Company regarding how it came to acquire the Shibu Inu tokens, if the tokens resided on the digital blockchain and which, if any, platforms allowed buying and selling of the Shibu Inu token. The Company responded on May 18, 2022 to FINRA’s questions. The Company intends to commence with the distribution of the tokens, through the www.beyondblockchain.us website once approved...